Control group:Valsartan capsule
Sponsors
Affiliated Hospital of Shandong University of TCM
Conditions
Essential hypertension
Early Phase 1
The Network Pharmacology and Mechanism Analysis of Xianxiong Chengqi Decoction in Treating Hypertension with Phlegm and Blood Stasis Syndrome
Active, not recruitingITMCTR2000003139
Start: 2020-03-31Updated: 2023-02-20
The Network Pharmacology and Mechanism Analysis of Xianxiong Chengqi Decoction in Treating Hypertension with Phlegm and Blood Stasis Syndrome
Active, not recruitingChiCTR2000031060
Start: 2020-03-31Updated: 2020-03-23
Mechanism and Clinical research of Zhenganxifeng dispensing granule decoction for treatment of hypertension with Yin Deficiency and Yang Hyperactivity Syndrome based on network pharmacology
Active, not recruitingITMCTR2000003146
Start: 2020-03-31Updated: 2023-02-20
Mechanism and Clinical research of Zhenganxifeng dispensing granule decoction for treatment of hypertension with Yin Deficiency and Yang Hyperactivity Syndrome based on network pharmacology
Active, not recruitingChiCTR2000031157
Start: 2020-03-31Updated: 2020-03-30
Unknown Phase
Clinical observation of Dachaihu decoction in the treatment of Irascibility hyperactivity syndrome(overabundant liver-fire syndrom) of hypertension
Active, not recruitingITMCTR2000003134
Start: 2020-03-31Updated: 2023-02-20
Clinical observation of Dachaihu decoction in the treatment of Irascibility hyperactivity syndrome(overabundant liver-fire syndrom) of hypertension
Active, not recruitingChiCTR2000030912
Start: 2020-03-31Updated: 2020-03-23
A randomized controlled trial for the clinical effect of Wu-Mei-Wan Decoction in the treatment of primary hypertension with upper heat and lower cold syndrome
Active, not recruitingITMCTR2000003155
Start: 2020-03-31Updated: 2023-02-20
A randomized controlled trial for the clinical effect of Wu-Mei-Wan Decoction in the treatment of primary hypertension with upper heat and lower cold syndrome
Active, not recruitingChiCTR2000031117
Start: 2020-03-31Updated: 2020-03-23